Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure grade* from Molecular Probes (Invitrogen)
Essential Techniques: Gel Electrophoresis: Proteins from Promega
Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen
Biology Products:(Date:11/6/2009)... To celebrate the 150th anniversary this month of ...merican Institute of Biological Sciences (AIBS) is... about Charles Darwin and his historic insights in...ian of the University of California, Berkeley, and...dian,s article, "Ten Myths About Charles Darwin," ...
(Date:11/6/2009)... PHILADELPHIA (November 06, 2009) The Monell Cent...o-hosts of the Beijing International Meeting on Ta...laboration with the CAS, the meeting will be the f...e held in China. , Alan Leshner, Chief Executive... of Science and Executive Publisher of Science mag...
(Date:11/5/2009)... Kent State University has been awarded a training... Science Foundation under its Integrative Graduati.... This is the first IGERT grant to be awarded to K...erican Recovery and Reinvestment Act of 2009, runs...t that focuses on environment aquatic resource sen...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Hospira Names Daphne E Jones Chief Information Officer 5611 1Hospira Names Daphne E Jones Chief Information Officer 5611 2Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 1Verizon Health Care Experts to Address 2009 Connected Health Symposium in Boston on Oct 21 59823 2Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 1Inverness Medical Innovations Schedules Conference Call for 10 3A00 a m ET October 27 2009 to Discuss Third Quarter 2009 Results 14544 2(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)... Calif., Nov. 6 Calbiotech, Inc. a...siness Innovative Research (SBIR) Phase I contract...mmand. Under terms of the agreement, Calbiotech wi...e diagnosis of Dengue virus. ,, Dengue virus...ajor threat to military forces deployed to tropica...
(Date:11/5/2009)...Md., Nov. 5 GenVec, Inc....sults for the third quarter ended September 30, 20....04 per share) for the three months ended Septembe...($0.08 per share) in the comparable quarter of 200...enVec,s net loss was $14.1 million ($0.15 per shar...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8